Procalcitonin as a Marker of Etiology in Community-Acquired Pneumonia

Clin Infect Dis. 2018 May 2;66(10):1639. doi: 10.1093/cid/cix1089.

Authors

Michael S Abers^{1

2}, Daniel M Musher^{3

4

5}

Affiliations

¹ Division of Infectious Diseases, Massachusetts General Hospital, Houston, Texas.
² Department of Medicine, Harvard Medical School, Boston, Massachusetts, Houston, Texas.
³ Department of Medicine, Baylor College of Medicine, Houston, Texas.
⁴ Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
⁵ Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.

PMID: 29360957
DOI: 10.1093/cid/cix1089

No abstract available

Publication types

Comment

MeSH terms

Adult
Community-Acquired Infections*
Humans
Pneumonia*
Procalcitonin

Substances

Procalcitonin